Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-021-02090-7.
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-03-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Online Access: | https://doi.org/10.1186/s13046-023-02626-z |
| _version_ | 1797863189383217152 |
|---|---|
| author | Guizhi Jia Yan Wang Chengjie Lin Shihui Lai Hongliang Dai Zhiqian Wang Luo Dai Huizhao Su Yanjie Song Naiwen Zhang Yukuan Feng Bo Tang |
| author_facet | Guizhi Jia Yan Wang Chengjie Lin Shihui Lai Hongliang Dai Zhiqian Wang Luo Dai Huizhao Su Yanjie Song Naiwen Zhang Yukuan Feng Bo Tang |
| author_sort | Guizhi Jia |
| collection | DOAJ |
| description | This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-021-02090-7. |
| first_indexed | 2024-04-09T22:32:40Z |
| format | Article |
| id | doaj.art-3ee3b465cd9347d59eb9e6afe020b9a0 |
| institution | Directory Open Access Journal |
| issn | 1756-9966 |
| language | English |
| last_indexed | 2024-04-09T22:32:40Z |
| publishDate | 2023-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Experimental & Clinical Cancer Research |
| spelling | doaj.art-3ee3b465cd9347d59eb9e6afe020b9a02023-03-22T12:41:24ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662023-03-014211110.1186/s13046-023-02626-zRetraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2Guizhi Jia0Yan Wang1Chengjie Lin2Shihui Lai3Hongliang Dai4Zhiqian Wang5Luo Dai6Huizhao Su7Yanjie Song8Naiwen Zhang9Yukuan Feng10Bo Tang11Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerDepartment of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerDepartment of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityThis article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-021-02090-7.https://doi.org/10.1186/s13046-023-02626-z |
| spellingShingle | Guizhi Jia Yan Wang Chengjie Lin Shihui Lai Hongliang Dai Zhiqian Wang Luo Dai Huizhao Su Yanjie Song Naiwen Zhang Yukuan Feng Bo Tang Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 Journal of Experimental & Clinical Cancer Research |
| title | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_full | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_fullStr | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_full_unstemmed | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_short | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_sort | retraction note lncarod enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform pkm2 |
| url | https://doi.org/10.1186/s13046-023-02626-z |
| work_keys_str_mv | AT guizhijia retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT yanwang retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT chengjielin retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT shihuilai retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT hongliangdai retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT zhiqianwang retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT luodai retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT huizhaosu retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT yanjiesong retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT naiwenzhang retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT yukuanfeng retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT botang retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 |